Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 4Psychological Well-Being 2Neoplasms 2Depression 2Anxiety Disorders 2Signs and Symptoms 1Motor Activity 1Fatigue 1Colon Cancer Screening 1Breast Cancer Female 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Self-Help Groups × Clear all
NCT04659993 2025-10-16

Cancer Within a Pandemic: A Telemental Health Intervention

Wake Forest University Health Sciences

Phase NA Terminated
10 enrolled 10 charts

Anxiety Disorders, Depression, Neoplasms

NCT01919853 2025-07-02

Treatment for Persistently Fatigued Cancer Survivors: A Randomized Controlled Trial With Biomarker Response

Indiana University

Phase NA Completed
107 enrolled

Fatigue, Neoplasms, Signs and Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡